Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients

Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of an symposium on the role of tuberculosis (TB) and cytomegalovirus (CMV) immunodiagnostics in hematopoietic cell transplant recipients. The theme of the symposium was to look at immunotesting, specifically the T-SPOT.TB and T-SPOT.CMV assays, and how they can help to better predict and diagnose TB and CMV in patients.
Recorded at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.